Research Purposes Only

PT-141 10mg (PT141) lyophilised research peptide vial — UK lab-tested, for research use only

Copper & Collagen Peptides

PT-141

10mg

C₅₀H₆₈N₁₄O₁₀

Key Research Findings

  • Characterisation of the cyclic heptapeptide with C-terminal carboxyl terminus.
  • Published MC3R / MC4R receptor-binding assay data.
  • In-vitro CNS receptor-distribution studies.

Overview

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin-receptor agonist with a free C-terminal carboxyl group. Supplied as a lyophilised powder for in-vitro research use only.

Mechanism of Action

Reported in published in-vitro studies as a melanocortin-receptor ligand active at MC3R and MC4R receptor-binding assays. Not intended for human or veterinary use.

Research Effects

MC3R / MC4R Receptor Binding

Extensive Research

Characterised in receptor-binding assays as a ligand of MC3R and MC4R melanocortin-receptor subtypes.

Receptor-Distribution Studies

Moderate Research

Published in-vitro studies report receptor-distribution profiles in cell-line and tissue assays.

MC1R Cross-Reactivity

Moderate Research

Receptor-selectivity studies report secondary MC1R binding under assay conditions tested.

Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.

Quick Facts

Molecular FormulaC₅₀H₆₈N₁₄O₁₀
Molecular Weight1025.17 g/mol
CAS Number189691-06-3
SequenceAc-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Half-Life~2.7 hours (animal pharmacokinetic data)
SolubilityWater (1 mg/mL)
Storage−20 °C
More in Copper & Collagen Peptides

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Related Peptides

How can we help?
Cart